logo

For the Inventor, By the Inventor

West Haven, CT, United States of America

John A McLane

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Hoffmann-La Roche Inc., Other. Active years: 1991-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John A McLane. Retrieved from https://idiyas.com/inventor/john-a-mclane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 110(Granted Patents)


Location History:

  • West Haven, CT (US) (1991 - 1995)
  • New Haven, CT (US) (1994 - 1998)

Company Filing History:

goldMedal8 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents
silverMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-1998

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5747478 - Vitamin D3 analogs for the treatment of psoriasis and sebaceous gland (1998-05-05),
2. 5428029 - Vitamin D3 fluorinated analogs (1995-06-27),
3. 5401733 - Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol (1995-03-28),
4. 5393900 - Steroid intermediates for the formation of vitamin D.sub.3 analogues (1995-02-28),
5. 5342833 - Vitamin D3 analogs (1994-08-30),
6. 5200549 - Antipsoriatic agents (1993-04-06),
7. 5073568 - Antipsoriatic agents (1991-12-17),
8. 5021451 - Method for inhibiting hyperproliferative diseases (1991-06-04),

Title: John A. McLane: Innovator in Dermatological Treatments

Introduction

John A. McLane is a notable inventor based in West Haven, CT (US), recognized for his contributions to dermatological treatments. With a total of 8 patents, he has made significant advancements in the field of skin disease therapies.

Latest Patents

Among his latest patents are innovative compounds aimed at treating various skin conditions. One of his notable inventions is a series of Vitamin D3 analogs designed for the treatment of psoriasis and sebaceous gland diseases. These compounds, characterized by specific formulas, are effective in addressing hyperproliferative skin diseases. Another significant patent involves Vitamin D3 fluorinated analogs, which are useful in treating not only skin disorders like psoriasis but also tumors and neoplastic diseases, including breast cancer and leukemia.

Career Highlights

Throughout his career, John A. McLane has worked with prominent companies, including Hoffmann-La Roche Inc. His work has focused on developing therapeutic agents that target skin diseases and related conditions.

Collaborations

John has collaborated with esteemed colleagues such as Milan R. Uskokovic and Thomas I. Doran, contributing to the advancement of dermatological research and innovation.

Conclusion

John A. McLane's work in developing effective treatments for skin diseases showcases his dedication to innovation in the medical field. His patents reflect a commitment to improving patient outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…